With the recent approval of Ocrevus (ocrelizumab) for both primary progressive and relapsing Multiple sclerosis Treatment Drug, interest in the medication is peaking. To help readers of Multiple Sclerosis News Today better understand this new medication and how it works, as well issues dealing with access, use, and potential side effects, here is a summary of the most relevant information now available about MS Drug.
Ocrevus MS Drug Side Effects Center
Ocrevus (ocrelizumab) injection is aCD20-directed cytolytic antibody indicated for the Multiple sclerosis treatment of patients with relapsing or primary progressive forms of multiple sclerosis (MS). Common side effects of MS Drug include:
- upper respiratory tract infections,
- infusion reactions (itching, rash, hives, redness, bronchospasm, swollen and sore throat, mouth pain, shortness of breath, flushing, hypotension, fever, fatigue, headache, dizziness, nausea, and fast heart rate),
- skin infections,
- lower respiratory tract infections,
- depression,
- back pain, and
- pain in the extremities.
Hepatitis B virus screening is required before the first dose of Ocrevus. Pre-medicate with methylprednisolone (or an equivalent corticosteroid) and an antihistamine prior to each infusion. The starting dose of this drug is 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses of Ocrevus are 600 mg intravenous infusion every 6 months. This drug may interact with other immune-modulating or immunosuppressive therapies, including immunosuppressant doses of corticosteroids. Tell your doctor all medications and supplements you use. this drug is not recommended for use during pregnancy; it may harm a fetus. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Ocrevus (ocrelizumab) Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
